IDEXX Laboratories, Inc. vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
7.5
Bullish
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
IDXX
High-quality business with 66% return on equity and 25% profit margins.
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
BUY
Target $724.50 (+27.7%)
14 analysts
BUY
Target $252.42 (+11.1%)
24 analysts
Fundamentals
IDXX
JNJ
43.3×
Trailing P/E
26.3×
34.6×
Forward P/E
17.9×
24.6%
Profit Margin
21.8%
61.8%
Gross Margin
68.0%
66.2%
ROE
26.4%
14.3%
Revenue Growth
9.9%
17.9%
Earnings Growth
-52.9%
1.72
Beta
0.33
—
Price / Book
—
$45.2B
Market Cap
$546.9B
$465 – $770
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →